Delays in maturation among adolescents with hemophilia and a history of inhibitors

Blood

Volumn 110, Issue 10, 2007, Pages 3656-3661

  Donfield, Sharyne M ^a   Lynn, Henry S ^b   Lail, Alice E ^a   Hoots, W Keith ^c   Berntorp, Erik ^d   Gomperts, Edward D ^e  

^a RHO INC   (United States)

^b FUDAN UNIVERSITY   (China)

^c West Houston Medical Center   (United States)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 INHIBITOR; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING DISORDER; BONE AGE; BONE MATURATION; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; COMORBIDITY; CONTROLLED STUDY; DRUG USE; HEIGHT; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PUBERTY; SIDE EFFECT; SUBSTITUTION THERAPY; TESTOSTERONE BLOOD LEVEL; VON WILLEBRAND DISEASE;

EID: 36348975208     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-05-088062     Document Type: Article

References (19)

1. Usner D, Donfield S, Sirois S, et al. Hemophilia morbidity, cognitive functioning, and academic achievement. J Pediatr. 1998;133:782-787.
2. Ekert H, Brewin T, Boey W, Davey P, Tilden D. Cost-utility analysis of recombinant factor VIIa (NovoSeven) in six children with long-standing inhibitors to factor VIII or IX. Haemophilia. 2001;7:279-285.
3. Soucie JM, Cianfrini C, Janco RL, et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood. 2004;103:2467-2473.
4. Dolan G. ESOS: a European study on the orthopaedic status of patients with haemophilia and inhibitors. Haemophilia. 2005;11:24-25.
5. Gertner J, Kaufman F, Donfield S, et al. Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development Study. J Pediatr. 1994;124:896-902.
6. Kaufman F, Gertner J, Sleeper L, Donfield S, for the Hemophilia Growth and Development Study. Growth hormone secretion in HIV-positive versus HIV-negative hemophilic males with abnormal growth and pubertal development. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:137-144.
7. Mahoney E, Donfield S, Howard C, Kaufman F, Gertner J, for the Hemophilia Growth and Development Study. HIV-associated immune dysfunction and delayed pubertal development in a cohort of young hemophiliacs. J Acquir Immune Defic Syndr. 1999;21:333-337.
8. + T-lymphocytes on growth measurements of hemophilic boys and adolescents. Pediatrics. 2001;107:e56-e60.
9. Hilgartner M, Donfield S, Willoughby A, et al. Hemophilia Growth and Development Study: design, methods, and entry data. Am J Pediatr Hematol Oncol. 1993;15:208-218.
10. Roche AF, Chumlea WC, Thissen D. Assessing the Skeletal Maturity of the Hand-Wrist: FELS Method. Springfield, Illinois: Charles C. Thomas; 1988.
11. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51:170-179.
12. Wong WY, Donfield SM, Rains E, FitzGerald G, Pearson SK, Gomperts ED. Frequency and causes of hospitalization in HIV-negative children and adolescents with hemophilia A or B and its effect on academic achievement. Haemophilia. 2004;10:27-33.
13. Sproul AHuang N. Growth patterns in children with cystic fibrosis. J Pediatr. 1964;65:664-676.
14. Lewy JE, New MI. Growth in children with renal failure. Am J Med. 1975;58:65-68.
15. Chumlea WC, Roche AF, Thissen D. The FELS method of assessing the skeletal maturity of the hand-wrist. Am J Hum Biol. 1989;1:175-183.
16. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13-23.
17. Espeland MA, Gallagher D, Tell GS, Davison LL, Platt OS. Reliability of Tanner stage assessments in a multi-center study. Am J Hum Biol. 1990;2:503-510.
18. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia. 2003;9:418-435.
19. Roche AF, Roberts J, Hamill PV. Skeletal maturity of youths 12-17 years: racial, geographic area, and socioeconomic differentials, United States, 1966-1970: data from the National Health Survey. 1978; PHS: series 11, no. 167.